The Northwestern Medicine Neuro COVID-19 research team discovered patients who continued to test positive more than 14 days after their initial positive test were more likely to experience delirium, longer hospital stays, were less likely to be discharged home, and had a greater six-month mortality than those without persistent viral shedding of COVID-19.
Tag: long-hauler
Penn Medicine Launches Region’s First Post-COVID-19 Neurological Care Clinic
As many as one in three COVID-19 survivors experience a mental health or neurological disorder, adding to a growing body of evidence that show COVID-19 can have serious and potentially long-lasting effects on the brain. The Penn Neuro COVID Clinic aims to assess and treat long-haul COVID patients suffering from neurological symptoms.
Among COVID-19 survivors, an increased risk of death, serious illness
A new study from Washington University School of Medicine in St. Louis shows that even mild cases of COVID-19 increase the risk of death in the six months following diagnosis and that this risk increases with disease severity. The comprehensive study also catalogues the wide-ranging and long-term health problems often triggered by the infection, even among those not hospitalized.
Existing Heart Failure Drug May Treat Potential COVID-19 Long-Hauler Symptom
UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
Investigating the Long-term Effects of COVID-19
Jefferson researchers join a CDC study to follow COVID-19 “long-haulers” and their symptoms.
COVID-19 Immunity May Last Six Months or More
People who have recovered from coronavirus can make potent antibodies to SARS-CoV-2 that evolve in the months after infection. These antibodies may be evolving in response to residual viral antigen hidden in the gut.